-
Biopharmaceuticals Contract Manufacturing Market to Reach USD $33.99 Billion by 2029 at 11.2% CAGR
25 Nov 2025 10:00 GMT
… the expansion of the biopharmaceutical contract manufacturing market. Personalized … Market?
Major players in the Biopharmaceuticals Contract Manufacturing include:
• … com/report/biopharmaceuticals-contract-manufacturing-global-market-report …
-
Senators Budd, Coons Lead Bicameral, Bipartisan Push to Reinvest in Domestic Biopharmaceutical Manufacturing
21 Nov 2025 19:29 GMT
… in biotechnology and strengthen domestic biopharmaceutical manufacturing. The bill reinvests … in domestic biopharmaceutical manufacturing by reducing dependence on … would create a National Biopharmaceutical Manufacturing Center of Excellence …
-
Bicameral, Bipartisan Bill Would Strengthen U.S. Biopharmaceutical Manufacturing
21 Nov 2025 02:29 GMT
… biotechnology and strengthen domestic biopharmaceutical manufacturing. Coons’ November … legislation reinvests in domestic biopharmaceutical manufacturing, reducing dependence on … and opportunities for scaling biopharmaceutical manufacturing, especially for …
-
MacroGenics to Participate in the 8th Annual Evercore Healthcare Conference
25 Nov 2025 21:05 GMT
… MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing innovative … .
MacroGenics (the Company) is a biopharmaceutical company focused on developing innovative …
-
Viking Therapeutics to Participate at the Piper Sandler 37th Annual Healthcare Conference
25 Nov 2025 22:47 GMT
… ;) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development … , Inc. is a clinical-stage biopharmaceutical company focused on the development …
-
Phio Pharmaceuticals Announces Completion of Enrollment in Phase 1b Clinical Trial of INTASYL siRNA Lead Compound PH-762
25 Nov 2025 20:07 GMT
… ) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its … ) is a clinical-stage siRNA biopharmaceutical company advancing its INTASYL® gene …
-
Congress introduces bill to create national biomanufacturing center of excellence
25 Nov 2025 20:11 GMT
… legislation to establish a National Biopharmaceutical Manufacturing Center of Excellence.
The … has gained regulatory approval, a biopharmaceutical company’s incentive to iterate …
-
BioAge Labs to Present at Piper Sandler 37th Annual Healthcare Conference
25 Nov 2025 21:30 GMT
… . BioAge is a clinical-stage biopharmaceutical company developing therapeutic product candidates …
-
CG Oncology to Present Results on Cretostimogene Grenadenorepvec at the Society of Urologic Oncology (SUO) 26th Annual Meeting
25 Nov 2025 21:05 GMT
… : CGON), a late-stage clinical biopharmaceutical company focused on developing and … is a late-stage clinical biopharmaceutical company focused on developing and …
-
Aardvark Therapeutics to Present at Upcoming Investor Conferences in December
25 Nov 2025 21:05 GMT
… ) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel … .
Aardvark is a clinical-stage biopharmaceutical company developing novel, small-molecule …